Plain-English translation of NCT02149004 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large research platform run by German universities and hospitals that brings together people living with HIV to study three important areas: preventing HIV infection, helping people live well with HIV over their lifetime, and exploring ways to potentially cure HIV. The platform operates at six major medical centers across Germany and aims to develop new vaccines, medicines, and strategies that could change how we treat and prevent HIV worldwide.
While current HIV medications can suppress the virus so well it becomes undetectable, people must take them for life — if treatment stops, the virus can return. This research platform exists to develop better prevention tools, improve long-term treatment options, and explore new approaches that might one day eliminate HIV completely from the body.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be part of a long-term research initiative at one of six German medical centers (in cities like Cologne, Munich, Hamburg, Heidelberg, Hannover, and others). The exact activities depend on which specific research project you join within the platform — some may involve sharing your health information, donating blood samples, or taking part in studies about new treatments or prevention strategies. The platform is actively recruiting and expects to involve around 10,000 people with HIV.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Germany
German Center for Infection Research, German Federal Ministry of Education and Research
Enrollment target
~10,000 participants
Started
April 2015
Primary completion
January 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2017.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jörg Janne Vehreschild, MD
University Hospital of Cologne
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.